These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 28625370)

  • 1. Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial.
    Lopes RD; Alings M; Connolly SJ; Beresh H; Granger CB; Mazuecos JB; Boriani G; Nielsen JC; Conen D; Hohnloser SH; Mairesse GH; Mabo P; Camm AJ; Healey JS
    Am Heart J; 2017 Jul; 189():137-145. PubMed ID: 28625370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and Design of the Evaluation of Oral Anticoagulation for Reduction of Thrombo-embolism in Chinese Patients with Device-Detected Subclinical Atrial Fibrillation (ART-CAF) Trial: an Open-Label Registry-Based Clinical Trial.
    Yang Y; Xu F; Tong J; Cai L; Jiang W; Sheng X; Pan Y; Jiang J; Zhang J; Jiang D; Zhao L; Fu G
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):389-396. PubMed ID: 30027309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation.
    Di Biase L; Callans D; Hæusler KG; Hindricks G; Al-Khalidi H; Mont L; Cosedis Nielsen J; Piccini JP; Schotten U; Kirchhof P
    Europace; 2017 Jan; 19(1):132-138. PubMed ID: 28130378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.
    Healey JS; Lopes RD; Granger CB; Alings M; Rivard L; McIntyre WF; Atar D; Birnie DH; Boriani G; Camm AJ; Conen D; Erath JW; Gold MR; Hohnloser SH; Ip J; Kautzner J; Kutyifa V; Linde C; Mabo P; Mairesse G; Benezet Mazuecos J; Cosedis Nielsen J; Philippon F; Proietti M; Sticherling C; Wong JA; Wright DJ; Zarraga IG; Coutts SB; Kaplan A; Pombo M; Ayala-Paredes F; Xu L; Simek K; Nevills S; Mian R; Connolly SJ;
    N Engl J Med; 2024 Jan; 390(2):107-117. PubMed ID: 37952132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.
    van Nieuwenhuizen KM; van der Worp HB; Algra A; Kappelle LJ; Rinkel GJ; van Gelder IC; Schutgens RE; Klijn CJ;
    Trials; 2015 Sep; 16():393. PubMed ID: 26340977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial.
    Pol T; Held C; Westerbergh J; Lindbäck J; Alexander JH; Alings M; Erol C; Goto S; Halvorsen S; Huber K; Hanna M; Lopes RD; Ruzyllo W; Granger CB; Hijazi Z
    J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29419390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial.
    Flaker G; Lopes RD; Hylek E; Wojdyla DM; Thomas L; Al-Khatib SM; Sullivan RM; Hohnloser SH; Garcia D; Hanna M; Amerena J; Harjola VP; Dorian P; Avezum A; Keltai M; Wallentin L; Granger CB;
    J Am Coll Cardiol; 2014 Oct; 64(15):1541-50. PubMed ID: 25301455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apixaban vs Aspirin According to CHA
    Lopes RD; Granger CB; Wojdyla DM; McIntyre WF; Alings M; Mani T; Ramasundarahettige C; Rivard L; Atar D; Birnie DH; Boriani G; Amit G; Leong-Sit P; Rinne C; Duray GZ; Gold MR; Hohnloser SH; Kutyifa V; Benezet-Mazuecos J; Cosedis Nielsen J; Sticherling C; Benz AP; Linde C; Kautzner J; Mabo P; Mairesse GH; Connolly SJ; Healey JS
    J Am Coll Cardiol; 2024 Jul; 84(4):354-364. PubMed ID: 39019530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment.
    Eikelboom JW; O'Donnell M; Yusuf S; Diaz R; Flaker G; Hart R; Hohnloser S; Joyner C; Lawrence J; Pais P; Pogue J; Synhorst D; Connolly SJ
    Am Heart J; 2010 Mar; 159(3):348-353.e1. PubMed ID: 20211294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apixaban: a new factor Xa inhibitor for stroke prevention in patients with nonvalvular atrial fibrillation.
    Lam S
    Cardiol Rev; 2013; 21(4):207-12. PubMed ID: 23535530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials.
    McIntyre WF; Benz AP; Becher N; Healey JS; Granger CB; Rivard L; Camm AJ; Goette A; Zapf A; Alings M; Connolly SJ; Kirchhof P; Lopes RD
    Circulation; 2024 Mar; 149(13):981-988. PubMed ID: 37952187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial.
    Kirchhof P; Blank BF; Calvert M; Camm AJ; Chlouverakis G; Diener HC; Goette A; Huening A; Lip GYH; Simantirakis E; Vardas P
    Am Heart J; 2017 Aug; 190():12-18. PubMed ID: 28760205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pre-procedural interrupted apixaban on heparin anticoagulation during catheter ablation for atrial fibrillation: a prospective observational study.
    Bin Abdulhak AA; Kennedy KF; Gupta S; Giocondo M; Ramza B; Wimmer AP
    J Interv Card Electrophysiol; 2015 Nov; 44(2):91-6. PubMed ID: 26292959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial.
    Easton JD; Lopes RD; Bahit MC; Wojdyla DM; Granger CB; Wallentin L; Alings M; Goto S; Lewis BS; Rosenqvist M; Hanna M; Mohan P; Alexander JH; Diener HC;
    Lancet Neurol; 2012 Jun; 11(6):503-11. PubMed ID: 22572202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes according to dose reduction criteria of apixaban in Japanese elderly patients with atrial fibrillation: J-ELD AF Registry subanalysis.
    Akao M; Yamashita T; Suzuki S; Okumura K;
    Heart Vessels; 2021 Jul; 36(7):1035-1046. PubMed ID: 33486555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.
    Lopes RD; Alexander JH; Al-Khatib SM; Ansell J; Diaz R; Easton JD; Gersh BJ; Granger CB; Hanna M; Horowitz J; Hylek EM; McMurray JJ; Verheugt FW; Wallentin L;
    Am Heart J; 2010 Mar; 159(3):331-9. PubMed ID: 20211292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of safety of left atrial catheter ablation procedures for atrial arrhythmias under continuous anticoagulation with apixaban versus phenprocoumon.
    Kaess BM; Ammar S; Reents T; Dillier R; Lennerz C; Semmler V; Grebmer C; Bourier F; Buiatti A; Kolb C; Deisenhofer I; Hessling G
    Am J Cardiol; 2015 Jan; 115(1):47-51. PubMed ID: 25456870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.
    Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Alexander JH; Atar D; Gersh BJ; Hanna M; Harjola VP; Horowitz JD; Husted S; Hylek EM; Lopes RD; McMurray JJ; Granger CB;
    J Am Coll Cardiol; 2014 Jan 7-14; 63(1):52-61. PubMed ID: 24055845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Apixaban Use Following Stroke in Patients With Atrial Fibrillation: Results of the AREST Trial.
    Labovitz AJ; Rose DZ; Fradley MG; Meriwether JN; Renati S; Martin R; Kasprowicz T; Murtagh R; Kip K; Beckie TM; Stoddard M; Bozeman AC; McTigue T; Kirby B; Tran N; Burgin WS;
    Stroke; 2021 Apr; 52(4):1164-1171. PubMed ID: 33626904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.